Manganese (Mn) is an essential metal for development and metabolism. However, exposures to high Mn levels may be toxic, especially to the central nervous system (CNS). Neurotoxicity is commonly due to occupational or environmental exposures leading to Mn accumulation in the basal ganglia and a Parkinsonian-like disorder. Younger individuals are more susceptible to Mn toxicity. Moreover, early exposure may represent a risk factor for the development of neurodegenerative diseases later in life. The present study was undertaken to investigate the developmental neurotoxicity in an in vivo model of immature rats exposed to Mn (5, 10 and 20 mg/kg; i.p.) from postnatal day 8 (PN8) to PN12. Neurochemical analysis was carried out on PN14. We focused on striatal alterations in intracellular signaling pathways, oxidative stress and cell death. Moreover, motor alterations as a result of early Mn exposure (PN8-12) were evaluated later in life at 3-, 4- and 5-weeks-of-age. Mn altered in a dose-dependent manner the activity of key cell signaling elements. Specifically, Mn increased the phosphorylation of DARPP-32-Thr-34, ERK1/2 and AKT. Additionally, Mn increased reactive oxygen species (ROS) production and caspase activity, and altered mitochondrial respiratory chain complexes I and II activities. Mn (10 and 20 mg/kg) also impaired motor coordination in the 3rd, 4th and 5th week of life. Trolox？, an antioxidant, reversed several of the Mn altered parameters, including the increased ROS production and ERK1/2 phosphorylation. However, Trolox？ failed to reverse the Mn (20 mg/kg)-induced increase in AKT phosphorylation and motor deficits. Additionally, Mn (20 mg/kg) decreased the distance, speed and grooming frequency in an open field test; Trolox？ blocked only the decrease of grooming frequency. Taken together, these results establish that short-term exposure to Mn during a specific developmental window (PN8-12) induces metabolic and neurochemical alterations in the striatum that may modulate later-life behavioral changes. Furthermore, some of the molecular and behavioral events, which are perturbed by early Mn exposure are not directly related to the production of oxidative stress.
References
[1]
Aschner JL, Aschner M (2005) Nutritional aspects of manganese homeostasis. Mol Aspects Med 26: 353–362.
[2]
Aschner M, Guilarte TR, Schneider JS, Zheng W (2007) Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol Appl Pharmacol 221: 131–147.
[3]
Dobson AW, Erikson KM, Aschner M (2004) Manganese neurotoxicity. Ann N Y Acad Sci 1012: 115–128.
[4]
Perl DP, Olanow CW (2007) The neuropathology of manganese-induced Parkinsonism. J Neuropathol Exp Neurol 66: 675–682.
[5]
Roth JA (2009) Are there common biochemical and molecular mechanisms controlling manganism and parkisonism. Neuromolecular Med 11: 281–296.
[6]
Erikson KM, Thompson K, Aschner J, Aschner M (2007) Manganese neurotoxicity: a focus on the neonate. Pharmacol Ther 113: 369–377.
[7]
Hafeman D, Factor-Litvak P, Cheng Z, van Geen A, Ahsan H (2007) Association between manganese exposure through drinking water and infant mortality in Bangladesh. Environ Health Perspect 115: 1107–1112.
[8]
Moreno JA, Streifel KM, Sullivan KA, Legare ME, Tjalkens RB (2009) Developmental exposure to manganese increases adult susceptibility to inflammatory activation of glia and neuronal protein nitration. Toxicol Sci 112: 405–415.
[9]
Moreno JA, Yeomans EC, Streifel KM, Brattin BL, Taylor RJ, et al. (2009) Age-dependent susceptibility to manganese-induced neurological dysfunction. Toxicol Sci 112: 394–404.
[10]
Rodier PM (1995) Developing brain as a target of toxicity. Environ Health Perspect 103: Suppl 673–76.
[11]
Bondy SC, Campbell A (2005) Developmental neurotoxicology. J Neurosci Res 81: 605–612.
Siddappa AJ, Rao RB, Wobken JD, Leibold EA, Connor JR, et al. (2002) Developmental changes in the expression of iron regulatory proteins and iron transport proteins in the perinatal rat brain. J Neurosci Res 68: 761–775.
[14]
Hardy G (2009) Manganese in parenteral nutrition: who, when, and why should we supplement? Gastroenterology 137: S29–35.
[15]
Gottlieb A, Keydar I, Epstein HT (1977) Rodent brain growth stages: an analytical review. Biol Neonate 32: 166–176.
[16]
Rice D, Barone S Jr (2000) Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108: Suppl 3511–533.
[17]
Lucchini R, Zimmerman N (2009) Lifetime cumulative exposure as a threat for neurodegeneration: need for prevention strategies on a global scale. Neurotoxicology 30: 1144–1148.
[18]
Santamaria AB (2008) Manganese exposure, essentiality & toxicity. Indian J Med Res 128: 484–500.
[19]
Burton NC, Guilarte TR (2009) Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates. Environ Health Perspect 117: 325–332.
[20]
Suzuki H, Takanashi J, Saeki N, Kohno Y (2003) Temporal parenteral nutrition in children causing t1 shortening in the anterior pituitary gland and globus pallidus. Neuropediatrics 34: 200–204.
[21]
Hardy G, Menendez AM, Manzanares W (2009) Trace element supplementation in parenteral nutrition: pharmacy, posology, and monitoring guidance. Nutrition 25: 1073–1084.
[22]
Garcia SJ, Gellein K, Syversen T, Aschner M (2006) A manganese-enhanced diet alters brain metals and transporters in the developing rat. Toxicol Sci 92: 516–525.
[23]
Lucaciu CM, Dragu C, Copaescu L, Morariu VV (1997) Manganese transport through human erythrocyte membranes. An EPR study. Biochim Biophys Acta 1328: 90–98.
[24]
Kannurpatti SS, Joshi PG, Joshi NB (2000) Calcium sequestering ability of mitochondria modulates influx of calcium through glutamate receptor channel. Neurochem Res 25: 1527–1536.
[25]
Chen MK, Lee JS, McGlothan JL, Furukawa E, Adams RJ, et al. (2006) Acute manganese administration alters dopamine transporter levels in the non-human primate striatum. Neurotoxicology 27: 229–236.
[26]
He L, Girijashanker K, Dalton TP, Reed J, Li H, et al. (2006) ZIP8, member of the solute-carrier-39 (SLC39) metal-transporter family: characterization of transporter properties. Mol Pharmacol 70: 171–180.
[27]
Anderson JG, Cooney PT, Erikson KM (2007) Inhibition of DAT function attenuates manganese accumulation in the globus pallidus. Environ Toxicol Pharmacol 23: 179–184.
[28]
Benedetto A, Au C, Aschner M (2009) Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease. Chem Rev 109: 4862–4884.
[29]
Hernandez RB, Farina M, Esposito BP, Souza-Pinto NC, Barbosa F Jr, et al. (2011) Mechanisms of manganese-induced neurotoxicity in primary neuronal cultures: the role of manganese speciation and cell type. Toxicol Sci.
[30]
Roth JA, Garrick MD (2003) Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese. Biochem Pharmacol 66: 1–13.
[31]
Zhang S, Fu J, Zhou Z (2004) In vitro effect of manganese chloride exposure on reactive oxygen species generation and respiratory chain complexes activities of mitochondria isolated from rat brain. Toxicol In Vitro 18: 71–77.
[32]
Tamm C, Sabri F, Ceccatelli S (2008) Mitochondrial-mediated apoptosis in neural stem cells exposed to manganese. Toxicol Sci 101: 310–320.
[33]
Zhang F, Xu Z, Gao J, Xu B, Deng Y (2008) In vitro effect of manganese chloride exposure on energy metabolism and oxidative damage of mitochondria isolated from rat brain. Environ Toxicol Pharmacol 26: 232–236.
[34]
Milatovic D, Zaja-Milatovic S, Gupta RC, Yu Y, Aschner M (2009) Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicol Appl Pharmacol 240: 219–225.
Avila DS, Gubert P, Fachinetto R, Wagner C, Aschner M, et al. (2008) Involvement of striatal lipid peroxidation and inhibition of calcium influx into brain slices in neurobehavioral alterations in a rat model of short-term oral exposure to manganese. Neurotoxicology 29: 1062–1068.
[37]
de Oliveira MR, de Bittencourt Pasquali MA, Silvestrin RB, Mello EST, Moreira JC (2007) Vitamin A supplementation induces a prooxidative state in the striatum and impairs locomotory and exploratory activity of adult rats. Brain Res 1169: 112–119.
[38]
Erikson KM, Suber RL, Aschner M (2002) Glutamate/aspartate transporter (GLAST), taurine transporter and metallothionein mRNA levels are differentially altered in astrocytes exposed to manganese chloride, manganese phosphate or manganese sulfate. Neurotoxicology 23: 281–288.
[39]
Xu B, Xu ZF, Deng Y (2010) Manganese exposure alters the expression of N-methyl-D-aspartate receptor subunit mRNAs and proteins in rat striatum. J Biochem Mol Toxicol 24: 1–9.
[40]
Hirata Y, Furuta K, Miyazaki S, Suzuki M, Kiuchi K (2004) Anti-apoptotic and pro-apoptotic effect of NEPP11 on manganese-induced apoptosis and JNK pathway activation in PC12 cells. Brain Res 1021: 241–247.
[41]
Latchoumycandane C, Anantharam V, Kitazawa M, Yang Y, Kanthasamy A, et al. (2005) Protein kinase Cdelta is a key downstream mediator of manganese-induced apoptosis in dopaminergic neuronal cells. J Pharmacol Exp Ther 313: 46–55.
[42]
Ito Y, Oh-Hashi K, Kiuchi K, Hirata Y (2006) p44/42 MAP kinase and c-Jun N-terminal kinase contribute to the up-regulation of caspase-3 in manganese-induced apoptosis in PC12 cells. Brain Res 1099: 1–7.
[43]
Gonzalez LE, Juknat AA, Venosa AJ, Verrengia N, Kotler ML (2008) Manganese activates the mitochondrial apoptotic pathway in rat astrocytes by modulating the expression of proteins of the Bcl-2 family. Neurochem Int 53: 408–415.
[44]
Yin Z, Aschner JL, dos Santos AP, Aschner M (2008) Mitochondrial-dependent manganese neurotoxicity in rat primary astrocyte cultures. Brain Res 1203: 1–11.
[45]
Jang BC (2009) Induction of COX-2 in human airway cells by manganese: role of PI3K/PKB, p38 MAPK, PKCs, Src, and glutathione depletion. Toxicol In Vitro 23: 120–126.
[46]
Cai T, Yao T, Zheng G, Chen Y, Du K, et al. (2010) Manganese induces the overexpression of alpha-synuclein in PC12 cells via ERK activation. Brain Res 1359: 201–207.
[47]
Li Y, Sun L, Cai T, Zhang Y, Lv S, et al. (2010) alpha-Synuclein overexpression during manganese-induced apoptosis in SH-SY5Y neuroblastoma cells. Brain Res Bull 81: 428–433.
[48]
Park EJ, Park K (2010) Induction of oxidative stress and inflammatory cytokines by manganese chloride in cultured T98G cells, human brain glioblastoma cell line. Toxicol In Vitro 24: 472–479.
[49]
Rao KV, Jayakumar AR, Reddy PV, Tong X, Curtis KM, et al. (2010) Aquaporin-4 in manganese-treated cultured astrocytes. Glia 58: 1490–1499.
[50]
Shin HJ, Choi MS, Ryoo NH, Nam KY, Park GY, et al. (2010) Manganese-mediated up-regulation of HIF-1alpha protein in Hep2 human laryngeal epithelial cells via activation of the family of MAPKs. Toxicol In Vitro 24: 1208–1214.
[51]
Cai T, Che H, Yao T, Chen Y, Huang C, et al. (2011) Manganese induces tau hyperphosphorylation through the activation of ERK MAPK pathway in PC12 cells. Toxicol Sci 119: 169–177.
[52]
Crittenden PL, Filipov NM (2011) Manganese modulation of MAPK pathways: effects on upstream mitogen activated protein kinase kinases and mitogen activated kinase phosphatase-1 in microglial cells. J Appl Toxicol 31: 1–10.
[53]
Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410: 37–40.
Thomas GM, Huganir RL (2004) MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci 5: 173–183.
[56]
Waetzig V, Herdegen T (2004) Neurodegenerative and physiological actions of c-Jun N-terminal kinases in the mammalian brain. Neurosci Lett 361: 64–67.
[57]
Mielke K, Herdegen T (2000) JNK and p38 stresskinases–degenerative effectors of signal-transduction-cascades in the nervous system. Prog Neurobiol 61: 45–60.
[58]
Cowan KJ, Storey KB (2003) Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J Exp Biol 206: 1107–1115.
[59]
Waetzig V, Zhao Y, Herdegen T (2006) The bright side of JNKs-Multitalented mediators in neuronal sprouting, brain development and nerve fiber regeneration. Prog Neurobiol 80: 84–97.
[60]
Brazil DP, Yang ZZ, Hemmings BA (2004) Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem Sci 29: 233–242.
[61]
van der Heide LP, Ramakers GM, Smidt MP (2006) Insulin signaling in the central nervous system: learning to survive. Prog Neurobiol 79: 205–221.
[62]
Graybiel AM (2005) The basal ganglia: learning new tricks and loving it. Curr Opin Neurobiol 15: 638–644.
[63]
Gerfen CR (2004) Basal ganglia. In: Paxinos G, editor. The rat nervous system. Amsterdam: Elsevier Academic. pp. 445–508.
[64]
Qi Z, Miller GW, Voit EO (2010) The internal state of medium spiny neurons varies in response to different input signals. BMC Syst Biol 4: 26.
[65]
Walaas SI, Hemmings HC , Greengard P, Nairn AC (2011) Beyond the dopamine receptor: regulation and roles of serine/threonine protein phosphatases. Front Neuroanat 5: 50.
[66]
Greengard P, Allen PB, Nairn AC (1999) Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23: 435–447.
[67]
Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, et al. (2004) DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol 44: 269–296.
[68]
Nishi A, Bibb JA, Snyder GL, Higashi H, Nairn AC, et al. (2000) Amplification of dopaminergic signaling by a positive feedback loop. Proc Natl Acad Sci U S A 97: 12840–12845.
[69]
Ahn JH, McAvoy T, Rakhilin SV, Nishi A, Greengard P, et al. (2007) Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56delta subunit. Proc Natl Acad Sci U S A 104: 2979–2984.
[70]
Greengard P (2001) The neurobiology of slow synaptic transmission. Science 294: 1024–1030.
[71]
Santini E, Valjent E, Usiello A, Carta M, Borgkvist A, et al. (2007) Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia. J Neurosci 27: 6995–7005.
[72]
Botsakis K, Pavlou O, Poulou PD, Matsokis N, Angelatou F (2010) Blockade of adenosine A2A receptors downregulates DARPP-32 but increases ERK1/2 activity in striatum of dopamine deficient “weaver” mouse. Neurochem Int 56: 245–249.
[73]
Lebel M, Chagniel L, Bureau G, Cyr M (2010) Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat. Neurobiol Dis 38: 59–67.
[74]
Polissidis A, Chouliara O, Galanopoulos A, Rentesi G, Dosi M, et al. (2010) Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain. Int J Neuropsychopharmacol 13: 1175–1191.
[75]
Sidoryk-Wegrzynowicz M, Lee E, Albrecht J, Aschner M (2009) Manganese disrupts astrocyte glutamine transporter expression and function. J Neurochem 110: 822–830.
[76]
Rocha JB, Pereira ME, Emanuelli T, Christofari RS, Souza DO (1995) Effect of treatment with mercury chloride and lead acetate during the second stage of rapid postnatal brain growth on delta-aminolevulinic acid dehydratase (ALA-D) activity in brain, liver, kidney and blood of suckling rats. Toxicology 100: 27–37.
[77]
Cordova FM, Rodrigues AL, Giacomelli MB, Oliveira CS, Posser T, et al. (2004) Lead stimulates ERK1/2 and p38MAPK phosphorylation in the hippocampus of immature rats. Brain Res 998: 65–72.
[78]
Fitsanakis VA, Zhang N, Anderson JG, Erikson KM, Avison MJ, et al. (2008) Measuring brain manganese and iron accumulation in rats following 14 weeks of low-dose manganese treatment using atomic absorption spectroscopy and magnetic resonance imaging. Toxicol Sci 103: 116–124.
[79]
Peterson GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83: 346–356.
[80]
Bjerrum OJ, Heegaard NHH (1988) CRC Handbook of Immunoblotting of Proteins.
[81]
Posser T, de Aguiar CB, Garcez RC, Rossi FM, Oliveira CS, et al. (2007) Exposure of C6 glioma cells to Pb(II) increases the phosphorylation of p38(MAPK) and JNK1/2 but not of ERK1/2. Arch Toxicol 81: 407–414.
[82]
Grimaldi Filho G (1981) Técnica histológica. S？o Paulo: Fiocruz.
[83]
Tolosa EMC, Rodrigues CJ, Behmer OA, Freitas Neto AG (2003) Manual de técnicas para histologia normal e patológica. Barueri: Manole.
[84]
Latini A, Rodriguez M, Borba Rosa R, Scussiato K, Leipnitz G, et al. (2005) 3-Hydroxyglutaric acid moderately impairs energy metabolism in brain of young rats. Neuroscience 135: 111–120.
[85]
Schuck PF, Tonin A, da Costa Ferreira G, Rosa RB, Latini A, et al. (2007) In vitro effect of quinolinic acid on energy metabolism in brain of young rats. Neurosci Res 57: 277–288.
[86]
Sauer H, Wefer K, Vetrugno V, Pocchiari M, Gissel C, et al. (2003) Regulation of intrinsic prion protein by growth factors and TNF-alpha: the role of intracellular reactive oxygen species. Free Radic Biol Med 35: 586–594.
[87]
Morrow JD, Roberts LJ 2nd (1999) Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol 300: 3–12.
[88]
Milatovic D, Yin Z, Gupta RC, Sidoryk M, Albrecht J, et al. (2007) Manganese induces oxidative impairment in cultured rat astrocytes. Toxicol Sci 98: 198–205.
[89]
Milatovic D, Aschner M (2009) Measurement of isoprostanes as markers of oxidative stress in neuronal tissue. Curr Protoc Toxicol Chapter 12: Unit12–14.
[90]
Zuse A, Prinz H, Muller K, Schmidt P, Gunther EG, et al. (2007) 9-Benzylidene-naphtho[2,3-b]thiophen-4-o？nesand benzylidene-9(10H)-anthracenones as novel tubulin interacting agents with high apoptosis-inducing activity. Eur J Pharmacol 575: 34–45.
[91]
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275.
[92]
Aguiar AS Jr, Araujo AL, da-Cunha TR, Speck AE, Ignacio ZM, et al. (2009) Physical exercise improves motor and short-term social memory deficits in reserpinized rats. Brain Res Bull 79: 452–457.
[93]
Lazrishvili IL, Shukakidze AA, Chkhartishvili NN, Bikashvili TZ (2009) Morphological changes and manganese content in the brains of rat pups subjected to subchronic poisoning with manganese chloride. Neurosci Behav Physiol 39: 7–12.
[94]
Dorman DC, Struve MF, Vitarella D, Byerly FL, Goetz J, et al. (2000) Neurotoxicity of manganese chloride in neonatal and adult CD rats following subchronic (21-day) high-dose oral exposure. J Appl Toxicol 20: 179–187.
[95]
Weber S, Dorman DC, Lash LH, Erikson K, Vrana KE, et al. (2002) Effects of manganese (Mn) on the developing rat brain: oxidative-stress related endpoints. Neurotoxicology 23: 169–175.
[96]
McDougall SA, Reichel CM, Farley CM, Flesher MM, Der-Ghazarian T, et al. (2008) Postnatal manganese exposure alters dopamine transporter function in adult rats: Potential impact on nonassociative and associative processes. Neuroscience 154: 848–860.
[97]
Wasserman GA, Liu X, Factor-Litvak P, Gardner JM, Graziano JH (2008) Developmental impacts of heavy metals and undernutrition. Basic Clin Pharmacol Toxicol 102: 212–217.
[98]
Menezes-Filho JA, Bouchard M, Sarcinelli Pde N, Moreira JC (2009) Manganese exposure and the neuropsychological effect on children and adolescents: a review. Rev Panam Salud Publica 26: 541–548.
[99]
Takeda A, Ishiwatari S, Okada S (1999) Manganese uptake into rat brain during development and aging. J Neurosci Res 56: 93–98.
[100]
Normandin L, Carrier G, Gardiner PF, Kennedy G, Hazell AS, et al. (2002) Assessment of bioaccumulation, neuropathology, and neurobehavior following subchronic (90 days) inhalation in Sprague-Dawley rats exposed to manganese phosphate. Toxicol Appl Pharmacol 183: 135–145.
[101]
Morello M, Canini A, Mattioli P, Sorge RP, Alimonti A, et al. (2008) Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats An electron spectroscopy imaging and electron energy-loss spectroscopy study. Neurotoxicology 29: 60–72.
[102]
Schneider JS, Decamp E, Clark K, Bouquio C, Syversen T, et al. (2009) Effects of chronic manganese exposure on working memory in non-human primates. Brain Res 1258: 86–95.
[103]
Fitsanakis VA, Zhang N, Garcia S, Aschner M (2010) Manganese (Mn) and iron (Fe): interdependency of transport and regulation. Neurotox Res 18: 124–131.
[104]
Rivera-Mancia S, Rios C, Montes S (2011) Manganese accumulation in the CNS and associated pathologies. Biometals 24: 811–825.
[105]
Guilarte TR, Chen MK, McGlothan JL, Verina T, Wong DF, et al. (2006) Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates. Exp Neurol 202: 381–390.
[106]
Sriram K, Lin GX, Jefferson AM, Roberts JR, Wirth O, et al. (2010) Mitochondrial dysfunction and loss of Parkinson's disease-linked proteins contribute to neurotoxicity of manganese-containing welding fumes. FASEB J 24: 4989–5002.
[107]
Kilbride SM, Telford JE, Davey GP (2008) Age-related changes in H2O2 production and bioenergetics in rat brain synaptosomes. Biochim Biophys Acta 1777: 783–788.
[108]
Bagh MB, Thakurta IG, Biswas M, Behera P, Chakrabarti S (2011) Age-related oxidative decline of mitochondrial functions in rat brain is prevented by long term oral antioxidant supplementation. Biogerontology 12: 119–131.
[109]
Barros MH, Bandy B, Tahara EB, Kowaltowski AJ (2004) Higher respiratory activity decreases mitochondrial reactive oxygen release and increases life span in Saccharomyces cerevisiae. J Biol Chem 279: 49883–49888.
[110]
Witte ME, Bo L, Rodenburg RJ, Belien JA, Musters R, et al. (2009) Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol 219: 193–204.
[111]
Heddi A, Stepien G, Benke PJ, Wallace DC (1999) Coordinate induction of energy gene expression in tissues of mitochondrial disease patients. J Biol Chem 274: 22968–22976.
[112]
Bandy B, Davison AJ (1990) Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Radic Biol Med 8: 523–539.
[113]
Hausladen A, Fridovich I (1994) Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem 269: 29405–29408.
[114]
Zhang Y, Marcillat O, Giulivi C, Ernster L, Davies KJ (1990) The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem 265: 16330–16336.
[115]
Radi R, Cassina A, Hodara R (2002) Nitric oxide and peroxynitrite interactions with mitochondria. Biol Chem 383: 401–409.
[116]
Aschner M, Erikson KM, Herrero Hernandez E, Tjalkens R (2009) Manganese and its role in Parkinson's disease: from transport to neuropathology. Neuromolecular Med 11: 252–266.
[117]
Posser T, Franco JL, Bobrovskaya L, Leal RB, Dickson PW, et al. (2009) Manganese induces sustained Ser40 phosphorylation and activation of tyrosine hydroxylase in PC12 cells. J Neurochem 110: 848–856.
[118]
McDougall SA, Der-Ghazarian T, Britt CE, Varela FA, Crawford CA (2011) Postnatal manganese exposure alters the expression of D2L and D2S receptor isoforms: relationship to PKA activity and Akt levels. Synapse 65: 583–591.
[119]
Murphy LO, Blenis J (2006) MAPK signal specificity: the right place at the right time. Trends Biochem Sci 31: 268–275.
[120]
Sweatt JD (2001) The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 76: 1–10.
[121]
Chu CT, Levinthal DJ, Kulich SM, Chalovich EM, DeFranco DB (2004) Oxidative neuronal injury. The dark side of ERK1/2. Eur J Biochem 271: 2060–2066.
[122]
Subramaniam S, Unsicker K (2006) Extracellular signal-regulated kinase as an inducer of non-apoptotic neuronal death. Neuroscience 138: 1055–1065.
[123]
Bae JH, Jang BC, Suh SI, Ha E, Baik HH, et al. (2006) Manganese induces inducible nitric oxide synthase (iNOS) expression via activation of both MAP kinase and PI3K/Akt pathways in BV2 microglial cells. Neurosci Lett 398: 151–154.
[124]
Liao SL, Ou YC, Chen SY, Chiang AN, Chen CJ (2007) Induction of cyclooxygenase-2 expression by manganese in cultured astrocytes. Neurochem Int 50: 905–915.
[125]
Andersson M, Usiello A, Borgkvist A, Pozzi L, Dominguez C, et al. (2005) Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. J Neurosci 25: 8432–8438.
[126]
Borgkvist A, Fisone G (2007) Psychoactive drugs and regulation of the cAMP/PKA/DARPP-32 cascade in striatal medium spiny neurons. Neurosci Biobehav Rev 31: 79–88.
[127]
Borgkvist A, Marcellino D, Fuxe K, Greengard P, Fisone G (2008) Regulation of DARPP-32 phosphorylation by Delta9-tetrahydrocannabinol. Neuropharmacology 54: 31–35.
[128]
Jones DC, Miller GW (2008) The effects of environmental neurotoxicants on the dopaminergic system: A possible role in drug addiction. Biochem Pharmacol 76: 569–581.
